Board Of Directors

Mr. Akshya Kumar Mahapatra is the visionary Founder & Managing Director of Aleafiaa Pharmaceuticals Pvt. Ltd., bringing over 30 years of distinguished experience in the pharmaceutical industry. Beginning his journey as a Medical Representative, he has steadily risen to leadership roles, including CEO and MD in renowned organizations. His expertise spans multiple therapeutic areas, including Oncology, Pediatrics, Respiratory, Critical Care, Orthopedics, and General Health.

With a deep understanding of both General Practitioners and Clinical Practitioners (GPCP) segments, he has seamlessly navigated the transition to Super Speciality domains, adapting to the evolving pharmaceutical landscape. His career includes pivotal roles at industry giants such as Wockhardt Ltd, Merck India Ltd, Glenmark, and PharmEasy.

As a strategic leader, Mr. Mahapatra has a proven track record of transforming large brands into industry-leading names and successfully establishing and scaling new ventures. His vision for Aleafiaa Pharmaceuticals is rooted in innovation, excellence, and delivering impactful healthcare solutions that drive better patient outcomes.

Mr. Adarsh Kumar Mahapatra is a dynamic leader with a strong background in finance and a keen strategic mindset for operational efficiency. As the Chief Operating Officer of Aleafiaa Pharmaceuticals Pvt. Ltd., he plays a pivotal role in streamlining business operations, optimizing resources, and driving sustainable growth.

With a deep understanding of financial management and business operations, Mr. Mahapatra has been instrumental in enhancing productivity, cost-effectiveness, and overall efficiency within the organization. His ability to integrate financial acumen with operational excellence ensures seamless execution of business strategies while maintaining the highest standards of compliance and quality.

Under his leadership, Aleafiaa Pharmaceuticals continues to strengthen its operational framework, leveraging data-driven decision-making and innovative process improvements to deliver impactful healthcare solutions. His commitment to efficiency and strategic foresight positions the company for long-term success in the evolving pharmaceutical landscape.